Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

Bile duct cancer, also known as cholangiocarcinoma, is a rare cancer that begins in the bile ducts. According to the American Cancer Society, about 8,000 people in the United States are diagnosed with this malignancy each year. According to bile duct cancer epidemiology forecast by Expert Market Research, epidemiological trends continue to influence the disease landscape and demand for diagnosis and treatment.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

Bile Duct Cancer – Number of Cases by Year

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Bile Duct Cancer Epidemiology Forecast Report Coverage

Expert Market Research's “Bile Duct Cancer Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of bile duct cancer. It projects the future incidence and prevalence rates of bile duct cancer cases across various populations. The study covers age, gender, and type as major determinants of the bile duct cancer population. The report highlights patterns in the prevalence of bile duct cancer over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of bile duct cancer in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Bile Duct Cancer Understanding: Disease Overview

Bile duct cancer, or cholangiocarcinoma, is a malignant tumor that develops in the bile ducts, which transport bile from the liver and gallbladder to the small intestine. It occurs when abnormal cells in the bile duct grow uncontrollably and form tumors, potentially obstructing bile flow. Based on its anatomical location, the disease is classified into intrahepatic, perihilar, and distal bile duct cancer. Risk factors include chronic bile duct inflammation, primary sclerosing cholangitis, certain liver diseases, and congenital abnormalities. Cholangiocarcinoma can vary in biological behavior and prognosis depending on its location and stage.

Key Report Insights

Parameter

Insight

Largest Patient Pool

United States

Fastest Growing Country

India

High-Risk Population

Older adults and individuals with chronic biliary conditions

Key Diagnostic Method

Imaging-based diagnosis, particularly MRI/MRCP and CT

Major Risk Factor

Primary sclerosing cholangitis and other chronic biliary diseases

Major gap in the market

Late diagnosis and limited early-detection strategies

Bile Duct Cancer Epidemiology Perspective

The bile duct cancer epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the bile duct cancer epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for bile duct cancer and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

Bile duct cancer is rare globally. According to the American Cancer Society (2026), about 8,000 people are diagnosed annually in the United States. Medanta reported fewer than 1,000 cases annually in India.

Gender-Specific Cases of the Disease

As per Pojsakorn Danpanichkul et al. (2025), early-onset liver and intrahepatic bile duct cancer incidence increased significantly among females, with an annual percent change of 3.07%, while rates remained stable in males.

Age-Specific Cases of the Disease

According to the American Cancer Society (2026), bile duct cancer occurs mainly among older adults, with the average age at diagnosis in the United States in the 70s. OT&P Limited noted a higher occurrence after age 50.

Ethnicity-Wise Cases of the Disease

As per Pojsakorn Danpanichkul et al. (2025), non-Hispanic American Indian and Alaska Native individuals had the highest early-onset liver and intrahepatic bile duct cancer incidence, at 2.67 per 100,000 population.

Mortality and Survival Analysis of the Disease

According to American Liver Foundation (2024), liver and intrahepatic bile duct cancer accounted for 29,840 estimated deaths in the United States in 2024, while five-year survival was approximately 22% during 2013–2019.

Type-Specific Disease Burden and Epidemiology Analysis

Disease Type

Prevalence

Intrahepatic Cholangiocarcinoma (iCCA)

Bile duct cancer arising within the liver. According to Gael S. Roth et al. (2024), intrahepatic cholangiocarcinoma has shown an increasing incidence in France, indicating a significant and growing share of the cholangiocarcinoma burden.

Perihilar Cholangiocarcinoma (pCCA)

Bile duct cancer arising at the hepatic hilum. It represents a major anatomical subtype of cholangiocarcinoma and contributes to the overall bile duct cancer burden across affected populations.

Distal Cholangiocarcinoma (dCCA)

It is the bile duct cancer that arises in the distal extrahepatic bile duct. It represents a significant anatomical subtype of cholangiocarcinoma and contributes to the overall epidemiological burden of bile duct cancer.

Bile Duct Cancer – Number of Cases by Country

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Country-wise Bile Duct Cancer Epidemiology

The bile duct cancer epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

According to American Cancer Society (2026), about 8,000 people are diagnosed with bile duct cancer annually. American Liver Foundation (2024) reported 9.4 cases per 100,000 for liver and intrahepatic bile duct cancer during 2017–2021.

Germany

Bile duct cancer represents a relatively uncommon cancer burden in Germany, with epidemiological patterns primarily concentrated among older adults. The available information supports assessment of incidence and prevalence alongside age-related disease distribution.

France

According to Gael S. Roth et al. (2024), biliary tract cancer incidence in 2018 was 2.1 per 100,000 men and 1.4 per 100,000 women, with incidence rising sharply from age 50.

Italy

Bile duct cancer remains an uncommon malignancy in Italy. Epidemiological assessment focuses on its occurrence across adult and older populations, alongside variations in incidence and disease burden within the broader biliary tract cancer population.

Spain

According to MD Anderson Cancer Center, more than 3,000 liver cancer cases are diagnosed annually in Spain, with rates of 14 per 100,000 men and 4 per 100,000 women; cholangiocarcinomas represent approximately 10–20% of liver cancer cases.

United Kingdom

Bile duct cancer epidemiology in the United Kingdom is characterized by occurrence predominantly among adults, particularly older populations. Assessment includes incidence patterns, age distribution, and differences in disease burden across demographic groups.

Japan

Bile duct cancer epidemiology in Japan is evaluated through incidence patterns and demographic distribution, with particular attention to disease occurrence among adult and older populations and variations in biliary tract cancer burden.

India

According to Medanta, fewer than 1,000 bile duct cancer cases are reported annually in India. Gael S. Roth et al. (2024) also identified Northern India as an area with a high incidence of gallbladder carcinoma.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

The bile duct cancer landscape across the United States, Germany, France, Italy, Spain, the United Kingdom, Japan, and India faces major gaps in early detection and timely diagnosis. Bile duct cancer is often identified at advanced stages, limiting curative treatment options and contributing to poor outcomes. Opportunities exist to strengthen surveillance among high-risk populations, improve access to advanced imaging and molecular diagnostics, and expand awareness of symptoms and risk factors. India represents an important emerging opportunity because improving cancer diagnosis and specialist access may increase case identification, while developed markets can benefit from precision diagnostics and personalized treatment approaches.

Bile Duct Cancer: Treatment Overview

Treatment for bile duct cancer depends on the tumor’s location, stage, resectability, and the patient’s overall health. Surgical resection is the primary potentially curative approach for localized, operable disease and may involve removing part of the liver, bile duct, or surrounding tissues. For unresectable or advanced disease, systemic therapy commonly includes chemotherapy, targeted therapy, and immunotherapy. Radiation therapy may be used for selected patients to control localized disease or relieve symptoms. Biliary drainage procedures, including stent placement, can help restore bile flow and manage obstruction. Systemic therapy is increasingly guided by molecular testing and tumor biomarkers.

Key Questions Answered

  • What is the current and projected burden of bile duct cancer across the 8 major markets?
  • Which countries across the 8 major markets account for the highest bile duct cancer patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of bile duct cancer across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of bile duct cancer across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of bile duct cancer across the 8 major markets?
  • How do major comorbidities and risk factors influence bile duct cancer epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of bile duct cancer across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the bile duct cancer landscape across the 8 major markets?
  • Which therapeutic areas linked to bile duct cancer are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the bile duct cancer epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on bile duct cancer epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for bile duct cancer across the 8 major markets?

Scope of the Bile Duct Cancer Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of bile duct cancer based on several factors.
  • Bile Duct Cancer Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The bile duct cancer report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Cancer Supportive Care Drugs Market

Cancer Therapeutics Market

Cancer Tumor Profiling Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us